CTAD 2018 | Progress In Mind

Home

Progress in Mind Resource Center reports from the 11th Clinical Trials on Alzheimer's Disease (CTAD)

Once again the Progress in Mind Resource Center brings you the latest reasearch within Alzheimer's Disease directly from CTAD.

Stay tuned as the Congress highlights become available or sign-up to our newsletter to receive updates directly to your mailbox.

Alzheimer's Disease

Read time: 3 min

Talking about biomarker test results in Alzheimer’s disease

We still need to understand how disclosure of a positive biomarker test for Alzheimer’s...

Alzheimer's Disease

Read time: 3 min

Inside the black box: Unlocking the potential of big data in neurodegenerative diseases

Big data, artificial intelligence and machine learning offer huge opportunities for the collection...

Alzheimer's Disease

Read time: 3 min

Congress highlights

A complete solution for patients with Alzheimer’s disease may be on the horizon

New treatments and improved diagnostic and staging tools will allow for a complete solution for...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Initial promise of immunotherapeutics targeting amyloid-β strengthens the possibility of early intervention in Alzheimer’s disease

Clinical studies of immunotherapies show initial promise for early intervention in Alzheimer’...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Active immunotherapy targets early stage Alzheimer’s disease

Active immunotherapies have been designed to activate an immune response in the human body of...

Alzheimer's Disease

Read time: 3 min

Congress highlights

The many faces of tau offer multiple targets for intervention in Alzheimer’s disease

Tau is a complex, multifaceted target, implicated in many mechanisms involved in the pathology of...

Alzheimer's Disease

Read time: 3 min

Congress highlights

It’s in the blood – identification of plasma biomarkers brings hope for screening and early detection of Alzheimer’s disease

The recent discovery and validation of blood biomarkers offers huge potential for the early...

Other conferences

Read time: Read time: 1 min

Read time: Read time: 1 min

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline